Schlorff Eric

SEC source: 0001437749-26-022573 · rdgdoc.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,140

F1 · shares: Represents a restricted stock unit award ("RSU"). The RSU will vest in three equal installment on July 1, 2026, November 1, 2026, and March 1, 2027.

SEC source: 0001437749-26-003668 · rdgdoc.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,852

F1 · shares: Represents an RSU award. The RSU award vests in equal installments on the first, second and third anniversaries of February 6, 2026

SEC source: 0001213900-25-061521 · marketforms-70035.xml · derivative · entry 2

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.0001 per share · 21,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ICU common stock.

F6 · derivative.exercise_date: As previously reported, on November 15, 2024, the reporting person was granted 65,000 RSUs, vesting in three approximately equal annual installments on the first, second and third anniversaries of July 1, 2024.

F6 · derivative.expiration_date: As previously reported, on November 15, 2024, the reporting person was granted 65,000 RSUs, vesting in three approximately equal annual installments on the first, second and third anniversaries of July 1, 2024.

F7 · balance_after: The total does not include 43,333 shares underlying RSUs that are now reported in Table I.

SEC source: 0001213900-25-061521 · marketforms-70035.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,517

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This Form 4 is being filed to report the vesting of certain restricted stock unit ("RSU") awards and the moving of unvested RSU awards previously reported in Table II to Table I.

F2 · shares: Reflects RSUs that upon vesting converted into shares of ICU common stock.

F3 · balance_after: The total includes 43,333 shares underlying RSUs that were previously reported in Table II.

F4 · balance_after: On June 7, 2024, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, all amounts of securities reported in this Form 4 have been adjusted to reflect the 1-for-25 reverse split.

SEC source: 0001213900-24-100246 · marketforms-67374.xml · derivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock, par value $0.0001 per share · 65,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ICU common stock.

F2 · derivative.exercise_date: The RSUs reported herein will vest in equal installments on the first, second and third anniversaries of July 1, 2024.

F2 · derivative.expiration_date: The RSUs reported herein will vest in equal installments on the first, second and third anniversaries of July 1, 2024.

SEC source: 0000929638-23-003302 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 837,823

F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

SEC source: 0000929638-23-002567 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 779,862

F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

SEC source: 0000929638-23-002513 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 738,753

F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

SEC source: 0000929638-23-003234 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 736,466

F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. Due to an administrative error, the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently overstated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 1,428 shares. This error has been corrected on this Form 4.

SEC source: 0000929638-23-002301 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 703,575

F1 · shares: The securities reported in this transaction are issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

SEC source: 0000929638-23-003233 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 702,176

F1 · shares: The securities reported in this transaction are issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. Due to an administrative error, the Form 4 filed for the Reporting Person on August 17, 2023 inadvertently overstated the number of shares of Common Stock issued to the reporting person on August 15, 2023 by 859 shares. This error has been corrected on this Form 4.

SEC source: 0000929638-23-001847 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 682,399

F1 · shares: Represents fully vested shares of common stock issued to the Reporting Person pursuant to the Issuer's equity incentive plan. Such fully vested shares of common stock are issued as payment for the occurrence of an exit event bonus under that certain Transaction Bonus Agreement, dated as of December 23, 2021, as amended, between the Issuer and the Reporting Person.

F2 · balance_after: Includes 66,483 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024.

SEC source: 0000929638-23-001151 · form4.xml · derivative · entry 2

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,724

Underlying: Common Stock · 99,724 shares

Expires 2033-04-06

F2 · derivative.exercise_date: All options reported herein will vest, subject to continued service, on the first anniversary of the date of grant.

SEC source: 0000929638-23-001151 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,013

F1 · shares: Represents the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest on the first anniversary of the date of grant.

SEC source: 0000899243-22-034685 · doc4.xml · derivative · entry 3

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,985

Underlying: Common Stock · 83,985 shares

Expires 2030-02-20

F2 · kind: Pursuant to the Merger Agreement, at the Effective Time, each outstanding option to purchase shares of SeaStar Medical common stock was assumed and converted into an option to purchase shares of common stock of the Issuer with the same terms and conditions as were applicable to such option immediately prior to the Effective Time, subject to the applicable exchange ratio.

F4 · derivative.exercise_date: The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from February 20, 2020 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from February 20, 2021.

SEC source: 0000899243-22-034685 · doc4.xml · derivative · entry 2

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,986

Underlying: Common Stock · 17,986 shares

Expires 2029-03-01

F2 · kind: Pursuant to the Merger Agreement, at the Effective Time, each outstanding option to purchase shares of SeaStar Medical common stock was assumed and converted into an option to purchase shares of common stock of the Issuer with the same terms and conditions as were applicable to such option immediately prior to the Effective Time, subject to the applicable exchange ratio.

F3 · derivative.exercise_date: The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from March 1, 2019 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from March 1, 2020.

SEC source: 0000899243-22-034685 · doc4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,530

F1 · kind: Represents the Issuer's common stock subject to restricted stock units (RSUs). Pursuant to the Agreement and Plan of Merger by and among the Issuer, LMF Merger Sub, Inc., and SeaStar Medical Inc. ("SeaStar Medical"), dated April 21, 2022 (as amended, the "Merger Agreement"), at the Effective Time (as defined in the Merger Agreement), each award of RSUs based on SeaStar Medical common stock that was outstanding immediately prior to the Effective Time was converted into the right to receive RSUs based on the common stock of the Issuer with the same terms and conditions as were applicable to such SeaStar Medical RSU awards immediately prior to the Effective Time, subject to the applicable exchange ratio. Fifty percent (50%) of the shares subject to RSUs reported herein will vest on the first anniversary of the Effective Time, thereafter the remaining will vest on a monthly basis over a 24-month period.